Pediatric Hypothyroidism Follow-up

Updated: Dec 20, 2016
  • Author: Sunil Kumar Sinha, MD; Chief Editor: Sasigarn A Bowden, MD  more...
  • Print
Follow-up

Further Outpatient Care

See the list below:

  • Once euthyroid, infants with congenital hypothyroidism should be observed every 3 months until they are aged 3 years. Thereafter, these children can be evaluated every 6 months.

Next:

Inpatient & Outpatient Medications

See the list below:

  • Levothyroxine is the appropriate replacement therapy for all clinically significant forms of hypothyroidism (see Medical Care).

Previous
Next:

Deterrence/Prevention

See the list below:

  • Screening of newborns for hypothyroidism is required by law in all 50 US states.

  • One preventable cause of congenital hypothyroidism is avoidance of administration of radioiodine to women who are pregnant. [7] Thus, women should undergo pregnancy testing before receiving radioiodine.

Previous
Next:

Complications

See the list below:

  • The etiology of adverse clinical outcomes is multifactorial. Even with optimal therapy, some children with congenital hypothyroidism display intelligence quotient values lower than would be expected on the basis of genetic potential. Factors associated with this adverse outcome include a markedly low T4 value at birth, a markedly delayed bone age at diagnosis, delay in treatment, and low serum T4 levels during the first year of therapy.

Previous
Next:

Prognosis

See the list below:

  • The prognosis for patients with congenital hypothyroidism that is appropriately treated within 6 weeks of birth is excellent.

  • Children with acquired hypothyroidism who receive adequate treatment at least 5 years before the onset of puberty typically achieve a final adult height consistent with their genetic potential. Overtreating with thyroid hormone does not enhance catch-up growth and may compromise final adult height by advancing osseous maturation.

Previous